Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SHE:002223)
China flag China · Delayed Price · Currency is CNY
29.00
-0.57 (-1.93%)
May 14, 2026, 3:04 PM CST

SHE:002223 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
7,8357,9017,5237,9197,0346,831
Other Revenue
54.0354.0342.952.8167.7763.18
7,8907,9557,5667,9727,1026,894
Revenue Growth (YoY)
1.53%5.14%-5.09%12.25%3.01%2.51%
Cost of Revenue
3,9223,9523,7963,9163,7093,586
Gross Profit
3,9684,0033,7704,0553,3933,308
Selling, General & Admin
2,2872,2391,7901,4991,4521,334
Research & Development
572.5570.15546.68504.37496.4425.67
Other Operating Expenses
142.0628.89-1.6932.9644.6731.99
Operating Expenses
3,0132,8422,3552,0272,0061,818
Operating Income
955.141,1611,4152,0291,3871,490
Interest Expense
-5.43-6-20.73-58.55-57.74-30.49
Interest & Investment Income
285.41283.33261.13357.97185.19156.79
Currency Exchange Gain (Loss)
-43.53-43.5319.693.6699.33-0.04
Other Non Operating Income (Expenses)
-32.82-0.68-0.94-2.41-1.4-1.79
EBT Excluding Unusual Items
1,1591,3941,6742,3291,6121,614
Impairment of Goodwill
-7.76-7.76-22.39-40.95-77.43-
Gain (Loss) on Sale of Investments
----4.112.162.17
Gain (Loss) on Sale of Assets
0.991.286.16555.26170.70.29
Asset Writedown
-1.1-1.33-2.09-13.66-1.99-0.86
Other Unusual Items
297.9297.9277.3123.03136.6385.75
Pretax Income
1,4491,6841,9332,8491,8421,702
Income Tax Expense
158.63200.36128.56472.36269.73217.82
Earnings From Continuing Operations
1,2901,4841,8042,3761,5731,484
Minority Interest in Earnings
-4.8-2.341.4319.3822.35-1.6
Net Income
1,2851,4821,8062,3961,5951,482
Net Income to Common
1,2851,4821,8062,3961,5951,482
Net Income Growth
-27.42%-17.94%-24.63%50.21%7.60%-15.73%
Shares Outstanding (Basic)
1,0021,001998994991995
Shares Outstanding (Diluted)
1,0021,001998994991995
Shares Change (YoY)
0.41%0.36%0.35%0.35%-0.42%-1.02%
EPS (Basic)
1.281.481.812.411.611.49
EPS (Diluted)
1.281.481.812.411.611.49
EPS Growth
-27.72%-18.23%-24.90%49.69%8.05%-14.86%
Free Cash Flow
1,3161,3741,6881,9941,926916.88
Free Cash Flow Per Share
1.311.371.692.011.940.92
Dividend Per Share
0.6000.6000.8000.8000.6000.300
Dividend Growth
-25.00%-25.00%-33.33%100.00%-
Gross Margin
50.29%50.32%49.83%50.87%47.77%47.99%
Operating Margin
12.11%14.60%18.70%25.45%19.53%21.61%
Profit Margin
16.29%18.63%23.87%30.05%22.46%21.50%
Free Cash Flow Margin
16.68%17.27%22.31%25.02%27.11%13.30%
EBITDA
1,1991,3991,6282,2361,5861,677
EBITDA Margin
15.20%17.59%21.51%28.04%22.33%24.33%
D&A For EBITDA
243.95237.73212.85206.92199.14187.27
EBIT
955.141,1611,4152,0291,3871,490
EBIT Margin
12.11%14.60%18.70%25.45%19.53%21.61%
Effective Tax Rate
10.95%11.89%6.65%16.58%14.64%12.80%
Revenue as Reported
7,8907,9557,5667,9727,1026,894
Advertising Expenses
-351.51171.34121.54147.18-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.